BeyondSpring Inc. (BYSI)

2,2200 +0,0200 (+0,91%) A partir del 10:00AM EDT. Mercado abierto.

BeyondSpring Inc.

28 Liberty Street
39th Floor
New York, NY 10005
United States
646 305 6387
https://beyondspringpharma.com

Sector(es): Healthcare
Sector: Biotechnology
Empleados a tiempo completo: 73

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Dr. Lan Huang Ph.D.	Co-Founder, Chairman & CEO	N/A	N/A	1971
Mr. Linqing Jia	Co-Founder	N/A	N/A	N/A
Dr. June Lu Ph.D.	Chief Scientific Officer	N/A	N/A	N/A
Stephen Kilmer	Head of Investor Relations	N/A	N/A	N/A
Mr. Gregg Russo	Senior Vice President of Human Resources	N/A	N/A	N/A

Los importes son a partir de y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of non-small cell lung cancer; ipilimumab, a CTLA-4 antibody for the treatment of extensive-stage small cell lung cancer; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.

Gobierno corporativo

El ISS Governance QualityScore de BeyondSpring Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.